Find Academic Supervisors

Katrina ChoeView profile

Assistant Professor

• Social Neuroscience
• Autism Spectrum Disorders
• Oxytocin Signaling
• +4 more

Katrina Choe serves as Assistant Professor in the Department of Psychology, Neuroscience & Behaviour at McMaster University and holds a Tier 2 Canada Research Chair in Neurobiology of Social Behaviour. Her research program investigates the multi-level neurobiological mechanisms underlying psychiatric disorders, with primary focus on autism spectrum disorders (ASD) and oxytocin signaling pathways. Her academic training includes: PhD in Neuroscience from McGill University (2013) Honours BSc in Zoology from University of Toronto (2002-2006) Postdoctoral Fellowship at UCLA (2013-2020) Dr. Choe's research employs an integrative approach spanning molecular, cellular, circuit, and network levels to examine how ASD-associated gene mutations disrupt social behavior. Current work centers on oxytocin signaling mechanisms in ASD, convergent neurobiological pathways across psychiatric disorders, and the role of glial cells in neural circuit function. Her lab utilizes advanced techniques including optogenetic fMRI, single-cell RNA sequencing, and multi-level behavioral assays in genetic mouse models. Analysis of her 15 most recent publications reveals a clear research trajectory: early work (2015-2020) established foundational knowledge in vasopressin neuron regulation and salt homeostasis, while recent publications (2022-2025) demonstrate a focused shift toward ASD mechanisms, oxytocin signaling, and social circuit dysfunction using the Cntnap2 knockout model. This evolution reflects her transition from postdoctoral training to independent research leadership. Her scientific recognition includes: Tier 2 Canada Research Chair in Neurobiology of Social Behaviour (2022) NIMH K99/R00 Award CIHR Postdoctoral Fellowship Dr. Choe actively mentors six graduate students across PhD and MSc programs while leading a dynamic research team comprising postdoctoral fellows, laboratory technicians, and undergraduate researchers. Her program receives substantial support from major grants including a 5-year CIHR Project Grant and NSERC Discovery Grant focused on 'The role of CASPR2 in central oxytocin system development.' The Choe Lab maintains active collaborations with leading neuroscience groups including the Bourque, Prager-Khoutorsky, and Cunningham labs, as evidenced by participation in the 4th 1000 Islands/Gananoque Meeting on Hypothalamic Mechanisms. Her laboratory, established in 2020, operates as a multidisciplinary hub utilizing molecular biology (qPCR, RNA-seq), advanced imaging (lightsheet, confocal), electrophysiology (in vitro and in vivo), and behavioral neuroscience approaches to investigate social behavior mechanisms. Current projects examine microglia-astrocyte-neuron interactions in social circuit function and the therapeutic potential of oxytocin for ASD-related social deficits.

Samuel FountainView profile

Professor

• Pharmacology
• Ion Channels
• Cardiometabolic Physiology
• +12 more

Professor Samuel Fountain is a leading academic in pharmacology at the University of East Anglia, where he serves as Chair of Pharmacology within the School of Biological Sciences. He holds additional leadership roles as Associate Pro-Vice-Chancellor of the UEA Doctoral College and has previously served as Associate Dean for Postgraduate Research and Director of the Biomedical Research Centre. He is actively supervising multiple PhD students and securing major research funding. BSc (Hons) Pharmacology, University of Leeds (1997–2000) MRC-funded PhD, University of Leeds (2000–2004) Wellcome Trust Research Associate, University of Manchester (2004–2008) BBSRC David Phillips Fellow, University of Leeds (2008–2010) Lecturer to Professor of Pharmacology, University of East Anglia (2010–present) His research focuses on the role of ion channels—particularly P2X receptors—in vascular and adipose tissues, with implications for cardiometabolic diseases. His work integrates pharmacology, physiology, and molecular biology to understand neurovascular and neuroadipose communication, receptor-ligand interactions, and drug discovery. He employs techniques such as pressure myography, patch-clamp electrophysiology, calcium imaging, and molecular modelling. The analysis of his recent publications reveals a strong emphasis on purinergic signalling, ion channel pharmacology, and autonomic control of blood vessels and fat tissue. His work bridges basic science with translational applications, particularly in hypertension, obesity, and metabolic syndrome. Collaborations with AstraZeneca, Merck, and the British Heart Foundation underscore the clinical and pharmaceutical relevance of his research. Notable scientific recognition includes the prestigious BBSRC David Phillips Fellowship. He also contributes to the academic community through editorial roles, including as Editor of Purinergic Signalling , and as a member of the British Pharmacological Society and The Physiological Society. Professor Fountain actively mentors postdoctoral researchers and PhD students, several of whom are funded by BBSRC, BHF, and AstraZeneca iCASE awards. His lab is supported by significant grants from the British Heart Foundation, BBSRC, and industry partners, enabling cutting-edge research in vascular and metabolic pharmacology. He leads multiple active projects on neurovascular transmission, purinergic control, and drug discovery for P2X receptors. His research group operates within the Cells and Tissues research theme at UEA and utilizes advanced experimental platforms including human tissue studies, high-throughput screening, and computational ligand docking. The lab fosters interdisciplinary collaboration between pharmacologists, physiologists, and clinicians, positioning it at the forefront of autonomic and metabolic research.

Marvin DiazView profile

Associate Professor

• Neurodevelopment
• Prenatal drug exposure
• Substance use disorder
• +3 more

Marvin Diaz is an Associate Professor and Behavioral Neuroscience Area Head at the Department of Psychology, Binghamton University. His research focuses on understanding neurobiological and behavioral alterations caused by early developmental insults such as prenatal drug exposure, with emphasis on sex differences. He employs advanced techniques including electrophysiology, optogenetics, and molecular biology. His work addresses mechanisms underlying anxiety disorders, substance misuse, and neurodevelopmental trajectories. Education: PhD and MA from Wake Forest University School of Medicine, BS from University of NC at Wilmington. Research Interests: Neurodevelopment, prenatal drug exposure, substance use disorder, neural circuits, and the role of sex as a biological variable. Key Findings: Demonstrated that prenatal methadone/alcohol exposure alters amygdala function, GABAergic transmission, and ethanol intake behavior in sex-dependent ways. Highlighted cytokine modulation of adolescent neurophysiology and stress-related behaviors. Awards: SUNY Faculty Diversity Award (202?), Gordon Conference Minority Fellowship (202?), Dean’s Research Semester Award (202?). Labs: Director of the Alcohol Development Lab. Active in studying developmental neurotoxicology and stress-anxiety interactions.

Juan SongView profile

Professor

• Adult Neurogenesis
• Neuroscience
• Neurodegenerative Diseases
• +5 more

Dr. Juan Song is a **Professor** and **Jeffrey Houpt Distinguished Investigator** in the Department of Pharmacology at the University of North Carolina (UNC) School of Medicine. Her research focuses on adult neurogenesis mechanisms, neural circuit regulation, and applications to neuropsychiatric disorders and neurodegenerative diseases such as Alzheimer’s. She leads the Song Lab, which employs advanced techniques like optogenetics, electrophysiology, and genetic models. Dr. Song earned her Ph.D. from UC Berkeley and completed postdoctoral training at Johns Hopkins University before establishing her independent lab at UNC in 2013. She was promoted to Full Professor in 2023. **Education**: Ph.D. in Neuroscience, University of California, Berkeley (2007); Postdoctoral Fellowship at Johns Hopkins University (2007–2013). **Research Interests**: Circuit mechanisms regulating adult neurogenesis, hippocampal neurogenesis and memory, Alzheimer’s disease modeling, and translational therapies. Her lab explores how neural circuits influence stem cell activation and newborn neuron integration, with implications for schizophrenia, autism, stroke, and Alzheimer’s. **Publications**: Over 50 peer-reviewed articles, including high-impact work in *Cell Stem Cell*, *Nature Neuroscience*, and *Neuron*. Recent studies focus on cholinergic circuits in neurogenesis, hypothalamic modulation of cognitive function, and G9a inhibitors for Alzheimer’s. **Advising & Grants**: Mentors postdocs, graduate students, and undergraduates. Active in training programs like BBSP and MSTP. Her lab collaborates on projects involving neural stem cell regulation and circuit-based therapies. **Lab & Affiliations**: Song Lab (UNC Neuroscience Center) develops innovative tools like transdermal drug delivery systems and employs cutting-edge imaging techniques. Collaborates with institutions globally on neurodegenerative disease research.

• Neurodegenerative Diseases
• Alzheimer's Disease
• Parkinson's Disease
• +12 more

Frédéric Calon is a Full Professor in the Faculty of Pharmacy at Université Laval, where he leads a prominent research program focused on neurodegenerative disorders, particularly Alzheimer’s and Parkinson’s diseases. His work bridges molecular neuroscience, nutritional interventions, and blood-brain barrier drug delivery, using both animal models and human post-mortem studies. He is actively involved in training graduate students and postdoctoral fellows and maintains international collaborations, including the LIA OptiNutriBrain with Bordeaux. B.Sc. in Biochemistry, Université Laval (1989–1992) M.Sc. in Pharmacy, Université Laval (1992–1995) B.Pharm., Université Laval (1994–1998) Ph.D. in Pharmacy, Université Laval (1998–2001) Postdoctoral Training, University of California, Los Angeles (UCLA), Dept. of Medicine (2001–2003) Dr. Calon’s research centers on three main axes: (1) the role of nutrition—especially omega-3 fatty acids—in neurodegeneration; (2) synaptic and molecular pathology in Alzheimer’s and Parkinson’s diseases; and (3) the interplay between peripheral metabolic disorders and brain health, including insulin signaling and thermoregulation. He also investigates the blood-brain barrier as a therapeutic gateway for drug delivery. His recent publications reflect a strong focus on Alzheimer’s disease mechanisms, including tau phosphorylation, amyloid-beta pathology, synaptic dysfunction, and the impact of diet and metabolism. He has also made key contributions to understanding essential tremor through post-mortem brain studies. His work frequently involves transgenic mouse models, such as the 3xTg-AD, and integrates behavioral, biochemical, and imaging techniques. Dr. Calon’s research is supported by major grants from CIHR and the Alzheimer Society of Canada. He mentors a large team of doctoral, master’s, and postdoctoral researchers, many of whom are supported by competitive scholarships. His lab has developed unique expertise in in situ brain perfusion and quantitative BBB transport analysis. He leads studies on novel therapeutic strategies, including repurposing beta-3 adrenergic agonists, optimizing nutraceutical formulations, and enhancing brain delivery of biologics via transferrin receptor-targeted vectors. His work on essential tremor has identified GABA receptor deficits and amyloid-beta accumulation in the cerebellum, suggesting a neurodegenerative basis for the disorder.

Michael WallaceView profile

Assistant Professor

• Electrophysiology
• Motivated Behavior
• Basal Ganglia
• +7 more

Michael Wallace serves as an Assistant Professor at Boston University, leading research at the intersection of basal ganglia circuitry, motivated behavior, and synaptic transmission mechanisms. His work addresses fundamental questions about neural control of goal-directed actions and their disruption in neurological disorders. Education: Ph.D. in Neurobiology from the University of North Carolina at Chapel Hill Dr. Wallace's research program centers on genetically defined circuits within the basal ganglia, investigating how these structures guide motivated behaviors and motor control. His laboratory employs a sophisticated multidisciplinary toolkit including in vivo electrophysiology, optogenetics, molecular genetics, computational modeling, and behavioral assays. Key research themes encompass neurotransmitter cotransmission (particularly GABA/glutamate interactions), synaptic vesicle dynamics, and circuit-level pathophysiology in conditions ranging from Parkinson's disease to addiction. The lab's long-term mission targets therapeutic interventions through mechanistic understanding of neural circuit dysfunction. Analysis of his publication record reveals consistent focus on multitransmitter neurons and basal ganglia microcircuitry since 2011, with increasing emphasis on entopeduncular nucleus function and neurotransmitter co-packaging mechanisms. His work demonstrates methodological evolution from anatomical and transcriptional profiling toward real-time circuit interrogation using optogenetic and electrophysiological approaches. The Wallace Lab operates as a dynamic neuroscience research hub, integrating expertise across molecular, cellular, and systems levels. Current investigations leverage cutting-edge techniques to dissect how specific basal ganglia pathways process motivational signals and motor commands, with particular attention to disease-relevant perturbations. This systems neuroscience approach bridges fundamental circuit mechanisms with translational applications for neurological and psychiatric disorders.

• Neuropharmacology
• Metabolic Disease Research
• Neuroendocrinology
• +5 more

Paula Goforth is an Assistant Professor at the University of Michigan Medical School , affiliated with the Department of Pharmacology and the Caswell Diabetes Institute . Her research focuses on the intersection of neuropharmacology and metabolic disease, particularly leptin signaling, orexin regulation, and hypothalamic circuits controlling glucose homeostasis and energy balance. Education: Postdoctoral training at Virginia Commonwealth University School of Medicine (2000-2004), specializing in Pharmacology under Dr. Satin LS. Her work explores neuron-specific metabolic regulation , including calcium channel modulation in obesity, orexin-glucose axis dynamics, and GABA-independent hypothalamic signaling. She employs techniques such as cell-type-specific circuit dissection and synaptic physiology to study these mechanisms. Recent publications highlight her expertise in leptin-regulated pathways , area postrema neuron function , and traumatic brain injury-related receptor changes , with implications for diabetes, obesity, and neurodegenerative diseases. Scientific Awards: NIH grants spanning 2013-2029, including dual awards for leptin action and gut-brain axis research Industry collaborations with Eli Lilly, Pfizer, and MedImmune LLC University of Michigan institutional support for diabetes/metabolic research Dr. Goforth's laboratory investigates metabolically coupled ion channels and neuronal population dynamics in metabolic disease models, with a strong emphasis on translational neuroscience applications.

Loic BinanView profile

Assistant Professor

• Cancer metastasis
• Spatial transcriptomics
• Gene regulatory networks
• +7 more

Loic Binan is an Assistant Professor in the Department of Human Genetics at McGill University, with additional affiliations as an Associate Member in the Department of Biomedical Engineering and the Integrated Program in Neuroscience. His research focuses on developing cutting-edge technologies to investigate how gene networks control the self-organization of cells into complex 3D tissues during development and in disease conditions. Dr. Binan's research interests span multiple interdisciplinary fields, with particular emphasis on cancer metastasis , where he investigates the genetic mechanisms allowing cells to reversibly transition between epithelial and mesenchymal phenotypes. His work also explores isoforms and non-coding regions , developing technologies to understand alternative splicing in neurodegenerative diseases, and examining how past cell-cell interactions shape present transcriptional activity during development. His laboratory employs a diverse array of techniques including CRISPR gene editing, spatial transcriptomics, single-cell RNA sequencing, advanced microscopy, and computational methods for image analysis. The recent publications reveal a strong trend toward integrating high-throughput genetic screening with spatial transcriptomics to map gene regulatory networks across both cancer biology and neuroscience contexts. Dr. Binan leads the Binan Lab at the Lady Davis Institute for Medical Research, where his team develops precision gene editing tools such as Cas9 and Cas12 for high-throughput screens, creates novel imaging tools to collect spatial context data, and builds computational tools to analyze these complex new data types. His research primarily focuses on cancer and neurodegenerative diseases, with particular attention to brain development and tumor microenvironments.

Arthur B PrindleView profile

Associate Professor

• Synthetic Biology
• Microbial Communities
• Biofilms
• +4 more

Arthur B Prindle is an Associate Professor in Biochemistry and Molecular Genetics and Microbiology-Immunology at Northwestern University's Feinberg School of Medicine, with a secondary appointment in McCormick School of Engineering. His research integrates synthetic biology and quantitative approaches to study collective behaviors in microbial communities. Education: PhD: University of California, San Diego (2014) Postdoctoral Fellow: University of California, San Diego, Molecular Biology (2016) Prindle's lab investigates molecular mechanisms of cell communication in biofilms using synthetic biology, microfluidics, and quantitative microscopy. Research focuses on engineering microbial communities for biomedical applications including inflammatory bowel disease detection, respiratory health improvement, and cancer biomarker discovery. The group develops "smart" biofilms capable of environmental detoxification and disease sensing through electrochemical signaling pathways. Recent publications (2021-2025) demonstrate interdisciplinary work spanning microbiome engineering, bacterial pathogenesis, and diagnostic tool development. Key themes include microbiome manipulation for therapeutic applications, multi-omics approaches to disease biomarkers, and fundamental studies of bacterial communication systems. Scientific Awards: NSF CAREER Award U.S. Army Research Office Early Career Award Pew Biomedical Scholar (2019) Packard Fellowship (2018, $875,000) Prindle leads an active research group supported by NSF, Army Research Office, and Packard Foundation grants. His lab recruits postdoctoral scholars, graduate students, and undergraduates for projects combining computational modeling with experimental synthetic biology. Current initiatives include developing engineered probiotics for human disease surveillance and exploring bacterial electrochemical signaling networks. The Prindle Lab operates within Northwestern's Simpson Querrey Institute for Epigenetics and collaborates with the Chemistry of Life Processes Institute and Robert H. Lurie Comprehensive Cancer Center. Located in the Simpson Querrey Research Building, the team utilizes custom microfluidic devices and advanced imaging to characterize metabolic and electrochemical dynamics in microbial communities.

Paul O'CallaghanView profile

Researcher

• Cell Biology
• Neuroscience
• Alzheimer's Disease Research
• +7 more

Paul O'Callaghan is a Researcher at Uppsala University's Department of Medical Cell Biology within the Faculty of Medicine. His work spans multiple disciplines at the intersection of cell biology, neuroscience, and biomedical engineering. Based at the BMC campus in Uppsala, he maintains an active research program with publications spanning from 2008 to the present, demonstrating sustained scholarly productivity. Dr. O'Callaghan's research interests focus on cellular mechanisms relevant to neurodegenerative diseases, particularly Alzheimer's disease, with emphasis on amyloid-beta pathology, heparan sulfate proteoglycans, and glial cell biology. His recent work has expanded into biomedical engineering applications including bioprinting, microfluidics, and biomaterials for neural applications. His publication record reveals a trajectory from fundamental cell biology toward translational applications, with consistent focus on cellular signaling mechanisms. O'Callaghan's recent publications (2021-2024) demonstrate a shift toward more engineering-focused approaches to biological problems, including 3D bioprinting, microfluidic cell culture systems, and biomaterial testing. His work maintains strong connections to both fundamental cell biology questions and potential clinical applications, particularly in neurodegenerative disease and cancer research. He leads his own research group within the Department of Medical Cell Biology, collaborating extensively with colleagues across Uppsala University including Johan Kreuger, Olle Eriksson, and other researchers in related fields. His work appears in high-impact journals across cell biology, neuroscience, and biomaterials disciplines.

• Theoretical Neuroscience
• Computational Neuroscience
• Behavioral Neuroscience
• +4 more

Dr. Ann Kennedy is an Assistant Professor of Neuroscience at Northwestern University's Feinberg School of Medicine, where she leads the Kennedy Lab. Her research focuses on theoretical neuroscience, using mathematical modeling and computational approaches to understand how neural circuits produce adaptive behaviors. She investigates how the brain integrates sensory information with survival needs to drive behavior across multiple scales, from single neurons to social groups. Dr. Kennedy received her BS and BA in Biomedical Engineering from Johns Hopkins University in 2008, followed by a PhD in Neuroscience from Columbia University in 2014. She conducted postdoctoral research at the California Institute of Technology before establishing her independent laboratory at Northwestern in 2020. Her research interests center on understanding the computational principles of neural circuits, particularly in subcortical brain regions involved in survival behaviors. She develops theories for distributed behavior control by multiple neural populations, studies computation in heterogeneous neural populations, and constructs richer descriptions of animal behavior using pose estimation and machine learning tools. Her work blends dynamical systems, control theory, reinforcement learning, and machine learning to investigate neural dynamics across multiple scales and model organisms. Dr. Kennedy's recent publications reveal trends in understanding neural heterogeneity, early nervous system evolution, and the theoretical foundations of neuroscience. Her work spans from fundamental computational principles to applications in pain research and behavioral neuroscience, with increasing emphasis on translating theoretical insights to understand neurological conditions. Sloan Research Fellowship, Sloan Foundation (2023) Eppendorf and Science Prize in Neurobiology (2022) McKnight Scholars Award (2024) Pew Scholar in the Biomedical Sciences (2024) Thom Young Researcher Award (2025) Dr. Kennedy actively mentors postdoctoral researchers and collaborates with experimentalists both locally and internationally. Her lab has received significant grant support including the $75,000 Sloan Fellowship and the prestigious McKnight Scholars Award. She co-chairs the CAJAL summer school on quantitative approaches to behavior and serves as Associate Editor for Science Advances. The Kennedy Lab operates at the intersection of theory and experiment, developing community resources like the Mouse Action Recognition System (MARS) for behavioral analysis and contributing to major initiatives like the 2025 Multi-Agent Behavior Challenge on Kaggle. The Kennedy Lab maintains active collaborations with researchers across San Diego and beyond, focusing on theoretical approaches to behavior and neural circuit function. Current projects analyze data from multiple brain regions and organisms, including hypothalamus studies of social and defensive behavior, basal ganglia research on behavior-neural activity correlations, hippocampal studies of social bond formation, and whole-organism neural imaging in cnidarians. The lab values open science, clear communication, and community resource development.

Emilia FavuzziView profile

Assistant Professor

• Neuroimmunomodulation
• Microglia
• Synaptic Development
• +4 more

Emilia Favuzzi is an Assistant Professor in the Department of Neuroscience at Yale University, affiliated with the Wu Tsai Institute and multiple interdisciplinary programs. She holds appointments in Immunology and the Interdepartmental Neuroscience Program. Her research focuses on neuroimmune interactions, particularly how microglia and other glial cells influence brain wiring and function during development and in health/disease. Education: B.S. & M.S. in Biology/Neurobiology from Sapienza University of Rome; Ph.D. in Neuroscience from Miguel Hernández University (Spain). Postdoctoral training at Harvard Medical School and the Broad Institute. Research interests include microglial-synapse interactions, immune encoding in cortical circuits, and links between immune challenges and neuropsychiatric disorders (e.g., Long COVID). Techniques employed include spatial transcriptomics, in vivo imaging, chemogenetics, and viral tools. Awards include the Gruber Neuroscience Award (2023), BBRF Young Investigator Grant (2023), and multiple early career honors. Her lab investigates how immune signals are integrated into brain networks and their implications for neurodevelopmental and psychiatric conditions.

• Neuropharmacology
• Medicinal Chemistry
• Pharmacology
• +7 more

Professor Jane Hanrahan is a leading academic in the School of Pharmacy at the University of Sydney, where she holds the rank of Professor in Pharmaceutical Sciences. She has served on the University of Sydney Academic Board since 2002 and chairs the Undergraduate Studies Committee, with prior roles in the Therapeutic Goods Administration Advisory Committee on Prescription Medicines (2013). Her career spans postdoctoral research at Cardiff (1996-97), lectureships in Pharmacology (1997-2002), and progressive promotions to Professor (2014). Education: BSc (Hons), University of Sydney PhD, University of Warwick (UK) Graduate Diploma in Educational Studies (Higher Education) Her research focuses on GABA receptors in anxiety, sleep disorders, schizophrenia, epilepsy, and learning/memory, with an emphasis on synthesizing conformationally restrained GABA analogues and exploring natural products from traditional herbal medicines. Key themes include neuropharmacology, medicinal chemistry, and mental health. Recent publications highlight trends in GABA receptor modulation (11/15 articles), traditional medicine analysis (4/15), and clinical pharmacy applications (4/15). Notable collaborations include work with Chebib, Johnston, and Collins on receptor-specific drug design. Grants and Committees: NHMRC Project Grants (2005-2014) on GABA receptors and neuroprotection Chair of Academic Board Undergraduate Studies Committee Member of Therapeutic Goods Administration Advisory Committee

Jennifer SteevesView profile

Professor

• Neuroscience
• Perceptual Neuroscience
• Cognitive Neuroscience
• +12 more

Jennifer Steeves is a Full Professor in the Department of Psychology, Faculty of Health at York University, where she also serves as Associate Vice President Research. She holds the York Research Chair in Non-invasive Visual Brain Stimulation and leads the Perceptual Neuroscience Laboratory. She is an active supervisor in the Biology Graduate Program and affiliated with multiple research institutes, including the Centre for Vision Research, Vision: Science to Applications (VISTA), and the SickKids Research Institute. She also holds adjunct professorships at the University of Toronto and the University of Waterloo. Her research focuses on how the brain adapts to sensory loss, particularly in individuals who have lost one eye early in life. She investigates neural plasticity using fMRI, TMS, psychophysics, and eye-tracking. Her work reveals structural and functional reorganization in the visual and auditory cortices, enhanced auditory localization, and reduced susceptibility to audiovisual illusions like the McGurk effect in monocular individuals. Her recent publications highlight the use of rTMS for treating visual hallucinations, cortical reorganization after sensory deprivation, and multisensory integration. These studies span clinical applications and fundamental neuroscience, showing trends in brain stimulation, neurochemical changes (GABA/glutamate), and cross-modal plasticity. York Research Chair in Non-invasive Visual Brain Stimulation Dr. Steeves has supervised numerous PhD, Master’s, and undergraduate students, many of whom have continued in neuroscience research. Her lab receives funding for studies on visual snow, Charles Bonnet Syndrome, and brain stimulation. She collaborates across disciplines and institutions, contributing to national networks like CAPnet. She actively mentors the next generation of scientists and leads major research initiatives at York University. The Perceptual Neuroscience Laboratory, located in the Sherman Health Science Research Centre at York University, brings together psychologists, neuroscientists, and clinicians. The lab utilizes fMRI, TMS, MR spectroscopy, and psychophysics to study both healthy and clinical populations, including those with retinoblastoma, prosopagnosia, and post-stroke visual impairments.

Ørjan Grøttem MartinsenView profile

Professor

• Bioimpedance
• Biomedical Physics
• Electronics and Instrumentation
• +3 more

Ørjan Grøttem Martinsen is a Professor of Electronics at the Department of Physics, Faculty of Mathematics and Natural Sciences, University of Oslo. He also holds a temporary research position at the Medical Technology Business Area of Oslo University Hospital. With over three decades of experience, he has established himself as a leading expert in bioimpedance research and applications. Education: High-voltage engineer degree (1983) Cand. scient. in electronics/measurement technology (1990) Dr. scient. with thesis on skin's electrical properties (1995) Professor Martinsen's research centers on bioimpedance—the passive electrical properties of biological tissues that vary with anatomy and physiology. His work spans diverse applications including medical diagnostics (skin cancer detection), food quality assessment (fresh vs. thawed fish), skin condition monitoring (moisture levels), and stress level evaluation. His research bridges physics, engineering, and medical applications, creating practical diagnostic tools from fundamental electrical principles. He has pioneered methods to characterize tissue properties through impedance measurements, with particular focus on electrodermal activity and skin impedance. His recent publications (2022-2025) demonstrate a strong interdisciplinary approach combining bioimpedance with machine learning, robotics, and advanced signal processing. The work spans from fundamental biophysics (GABA detection, tissue characterization) to practical applications (dental anxiety assessment, ADHD treatment evaluation). Key trends include integration of AI with bioimpedance measurements, development of novel sensor systems, and expansion into new application areas like optogenetics and micro-robotics. Awards and Recognition: IEEE Senior Member (2006) CLABIO Award (2012) Fellow at Institute of Physics (FInstP) (2015) Dr. Honoris Causa, Tallinn University of Technology (2018) UiO Innovation Award (2019) Member of Norwegian Academy of Technical Sciences (2021) Professor Martinsen has served as Editor-in-Chief of the Journal of Electrical Bioimpedance since 2010 and was President of the International Society for Electrical Bioimpedance (2010-2016). His research has attracted significant funding, enabling collaborations across engineering, medical, and biological disciplines. He has supervised numerous students and researchers in the Bioimpedance Group at UiO, fostering a strong research environment that bridges theoretical and applied work. His work is conducted primarily through the Oslo Bioimpedance Group and Sensorama SmartSense research teams, which focus on developing innovative measurement techniques and applications of bioimpedance technology. These groups maintain strong collaborations with medical institutions and industry partners to translate research findings into practical healthcare solutions.